A director at Arista Networks Inc sold 8,000 shares at 125.950USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Microchip Technology Earns IEC 62443-4-1 ML2 Industrial Automation and Control System Certification Secure Development Processes Advance CRA Readiness and Increase Customer Cybersecurity Assurance CHANDLER, Ariz., April 02, 2026 (GLOBE NEWSWIRE) -- As connected systems spread across residential, industrial and commercial environments, the need for independently verified cybersecurity assurance is becoming a core requirement. To help address this demand, Microchip Technology (Nasdaq: MCHP) has been certified by UL Solutions to the IEC 62443‑4‑1 Maturity Level 2 (ML2) Industrial Automatio...
CVS Health Corp. (CVS - $72.49)Omnicare Advances Court-Supervised Process; Stalking Horse Bidder Named; Chapter 11 Auction Set. Omnicare, a subsidiary of CVS, announced on April 1, 2026, it has entered into an asset purchase agreement with GenieRx Holdings LLC, a joint venture between private inves
We publish today our comprehensive quarterly bible: 243 pages of detailed analyses on what happened in the last 3 months, and how we interpret it, in light of our current convictions. The first section acts as a PM summary, outlining our key findings, and latest thoughts on the semi cycle, in 6 slides:
The recovery has largely played out in Legacy, but growth rates keep accelerating. With agentic AI driving demand for traditional infrastructure, this could create positive surprises. Public-cloud growth also accelerates on broad-based strength across AI and traditional workloads. SaaS revenue growth remains in the low-teens with no sign of material reacceleration, suggesting that low-teens growth is becoming the new normal.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.